BioPharm International-09-01-2007

Columns and Departments

September 01, 2007

In analyzing the industry's current challenges, let's be careful before extrapolating about what they mean.

Columns and Departments

September 01, 2007

Meeting service levels is a major challenge for pharmaceutical services providers because the requirements of their client base vary widely.

Columns and Departments

September 01, 2007

The new legislation authorizes the use of fee revenues for drug safety oversight and assessment throughout a product's lifecycle.

There were notable approvals in nonparenteral delivery systems and biosimiliars in 2006.

Columns and Departments

September 01, 2007

In light of these recent decisions, patent holders must devise new strategies for patent enforcement and licensing.

Columns and Departments

September 01, 2007

Closer examination shows there's a strong bond between the biotech market and the unraveling credit markets.

From the earliest days of the biotechnology industry, companies have grappled with the complexities of making innovative biopharmaceuticals on a large scale. Success in manufacturing begins with process science, since biotech production requires perfection in maintaining living organisms in a sterile environment under controlled physiological conditions. But unless companies can solve the challenge of planning for and managing manufacturing capacity, they will not be able to achieve the full potential of promising biotech products.